Cervicovaginal inflammation and HIV target cell activation in adolescent girls and young women with Chlamydia trachomatis infections
Open Access
- 2 July 2026
- journal article
- Published by BMJ in Sexually Transmitted Infections
Abstract
Background: Adolescent girls and young women (AGYW) in sub-Saharan Africa are disproportionately affected by Chlamydia trachomatis (CT) infections, a leading cause of pelvic inflammatory disease, infertility and increased HIV susceptibility. CT-induced genital inflammation disrupts mucosal barriers and activates HIV target cells, compounding immunological risks. We investigated CT infection in AGYW from two South African regions, focusing on genital inflammation and immune activation. Methods: An observational cohort of 298 sexually active AGYW (aged 16–22 years) from Cape Town and Johannesburg was enrolled. Participants in Johannesburg attended one visit, while those in Cape Town were followed longitudinally (6–8 months). Cytokine profiling of cervicovaginal samples assessed inflammatory responses, while cervical cytobrush-derived CD4+ T cells were analysed for CD38, Ki67 and C-C chemokine receptor type 5 expression. CT ompA genotyping examined strain diversity. Results: CT prevalence was 2.4-times higher in Cape Town (41.6%) than Johannesburg (17.4%). CT infection was associated with upregulated interleukin (IL)-1β, IL-6 and tumour necrosis factor (TNF)-α, with responses appearing stronger in Johannesburg, although low CT cases at this site limited regional comparisons. Genotyping suggested regional variation: genovar D, predominant in Cape Town, was associated with lower interferon (IFN)-γ concentrations, whereas genovar E, more common in Johannesburg, was associated with higher IFN-γ concentrations. AGYW with CT infection across multiple visits did not exhibit elevated genital tract cytokine levels compared with those infected at a single visit. However, they showed increased activated cervical CD4+ T cells. Conclusions: CT-associated immune responses in AGYW appear to reflect a combination of pathogen diversity, regional context and host immune history.Keywords
Funding Information
- European and Developing Countries Clinical Trials Partnership (SP.2011.41304.038)
- South African Medical Research Council (2017-2020)
This publication has 23 references indexed in Scilit:
- Chlamydia trachomatis -specific T Cell Immunity Reflects Widespread Exposure in South African Adolescents and Young WomenThe Journal of Infectious Diseases, 2025
- Lower genital tract cytokine profiles in South African women living with HIV: influence of mucosal samplingScientific Reports, 2018
- Pathology after Chlamydia trachomatis infection is driven by nonprotective immune cells that are distinct from protective populationsProceedings of the National Academy of Sciences, 2018
- Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic studyThe Lancet HIV, 2017
- Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cellsMucosal Immunology, 2016
- Genital Inflammation and the Risk of HIV Acquisition in WomenClinical Infectious Diseases, 2015
- Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typingNature Genetics, 2012
- Use of an expanded gold standard to estimate the accuracy of colposcopy and visual inspection with acetic acidInternational Journal of Cancer, 2009
- Chlamydia trachomatisGenotypes: Correlation with Clinical Manifestations of Infection and Patients' CharacteristicsClinical Infectious Diseases, 1998
- Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.Journal of Experimental Medicine, 1990